Saturday 17 October 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
56.09
1.69
−2.92%
Follow ATRC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(6.11%) | (2.40%) | (0.97%) | 2.15% | |
Piotroski F-Score |
6 | 6 | 7 | 8 | |
| (4.60%) | (1.81%) | (0.74%) | 1.64% | ||
ROIC |
(4.11%) | (1.48%) | (0.44%) | 1.92% | |
Return on Tangible Assets |
(10.95%) | (4.09%) | (1.64%) | 3.45% | |
Average Days of Receivables |
44.35 | 45.51 | 47.14 | 51.25 | |
Free Cash Flow per Share |
0.69 | 1.01 | 1.11 | 1.09 | |
Free Cash Flow |
33.00 | 48.28 | 53.64 | 53.11 | |
Capital Expenditures |
(10.14) | (9.05) | (10.72) | (11.82) | |
| Other line items | |||||
Cash ROIC |
4.73% | 6.59% | 7.56% | 7.03% | |
Accounts Receivable Turnover |
8.79 | 8.42 | 8.20 | 7.80 | |
Accounts Payable Turnover |
4.55 | 5.31 | 4.83 | 4.39 | |
Inventory Turnover |
1.68 | 1.74 | 1.73 | 1.68 | |
Average Days of Payables |
71.38 | 69.07 | 82.81 | 96.92 | |
Days of Inventory on Hand |
221.25 | 214.20 | 219.88 | 226.89 | |
Tax Rate |
0.03 | 0.13 | 0.41 | (0.13) | |
Research and Development Expense of Revenue |
21.16% | 18.56% | 18.28% | 17.21% | |
Selling, General and Administrative Expense of Revenue |
58.82% | 58.19% | 57.87% | 56.82% | |
Share Based Compensation of Revenue |
8.45% | 8.36% | 8.39% | 8.30% | |
Interest Coverage |
(4.54) | (1.61) | (0.51) | 2.29 | |
Operating CF/Net income |
(1.50) | (5.01) | (14.01) | 6.15 | |
Depreciation/Fixed assets |
0.52 | 0.54 | 0.53 | 0.50 | |
Capex/Depreciation |
(0.49) | (0.43) | (0.51) | (0.55) | |
Revenue per Share |
10.82 | 11.19 | 11.42 | 11.70 | |
Operating CF per Share |
0.90 | 1.20 | 1.33 | 1.33 | |
Capex per Share |
(0.21) | (0.19) | (0.22) | (0.24) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates